PharmaThe Demographic Revolution of HealthcarePharma 2010: The Threshold of Innovation (IBM)Pharma 2005: Marketing to the individual (IBM)Pharma 2005: An industrial Revolution in R&D (IBM)Top 50 PharmaPharma Overview (C&EN, 2002)Pharma Supply Chain and Product Life cycleAdvanced Drug Delivery Technology and Product Life CycleMaine Rx and PharmaTypes of M&A in Pharma Industry HorizontalVerticalConcentricAcquisition by Conglomerates Patient Groups: the rise and rise of consumer-powerDevelopment of the medicine business in ChinaAsian Markets to reach 30 billion by 2005New EU drug regulations positioned to boost new introductions and competitionBlockbuster ecosystems: sustainable developmentThe European Generics Outlook: A country-by-country analysis of developing market opportunities and revenue defense strategiesThe Outlook For The Biotech Sector In The Post-Genomic Era: Strategies for drug discovery, diagnostics and personalized medicinePharmaceutical Strategic Alliances: Benchmarking 21st century deal-makingPharmacy2002 Community Pharmacy ResultThe impact of e-pharmacy on the pharmaceutical industry
Pharma
The Demographic Revolution of Healthcare
Pharmacy
Pharmaceutical ConsultantsURCH PublishingPriceWaterCooperHouse Pharma Cutting Edge Info IMS Health Decision Resources Best Practices DatamonitorIBM Global Services-Life Sciences